WallStSmart
AUTL

Autolus Therapeutics Ltd

NASDAQ: AUTL · HEALTHCARE · BIOTECHNOLOGY

$1.41
+0.00% today

Updated 2026-04-30

Market cap
$383.25M
P/E ratio
P/S ratio
355.35x
EPS (TTM)
$-1.08
Dividend yield
52W range
$1 – $3
Volume
1.7M

WallStSmart proprietary scores

35
out of 100
Grade: D
Sell
Investment rating
8.0
Growth
A
5.0
Quality
C+
2.5
Profitability
F
6.7
Valuation
B
/9
Piotroski F-Score
Altman Z-Score
Industry rank
View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target
$8.81
+524.82%
12-Month target
Intrinsic (DCF)
$3.39
Margin of safety
+57.82%
1 Strong Buy10 Buy0 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths
+ Revenue growth 83,655.00% QoQ
+ 57.82% below intrinsic value
Risks
- Thin margins at 0.00%
- Negative free cash flow $-91.09M

Key financials

Revenue Net Income Free Cash Flow
Metric2022202320242025TTM
Revenue$6.19M$1.70M$10.12M$75.56M$1.08M
Net income$-148.84M$-208.38M$-220.66M$-287.53M$-90.20M
EPS$-1.08
Free cash flow$-123.15M$-156.57M$-241.09M$-302.66M$-91.09M
Profit margin-2,402.95%-12,272.26%-2,180.45%-380.51%

Peer comparison

CompanyMkt CapScoreGrowthProfitValueQualityMoSRating
AUTL$383.25M358.02.56.75.0+57.82%Hold
LLY$760.43B7810.010.05.06.5Strong Buy
JNJ$547.28B594.79.03.36.0-43.54%Buy
ABBV$360.63B634.08.04.75.0-29.31%Buy
UNH$322.34B545.35.57.34.8+42.06%Buy
AZN$294.17B646.78.05.35.0+4.07%Buy

Smart narrative

Autolus Therapeutics Ltd trades at $1.41. Our Smart Value Score of 35/100 indicates the stock is weak. TTM revenue stands at $1.08M. Our DCF model estimates intrinsic value at $3.39.

Frequently asked questions

What is Autolus Therapeutics Ltd's stock price?
Autolus Therapeutics Ltd (AUTL) trades at $1.41.
Is Autolus Therapeutics Ltd overvalued?
Smart Value Score 35/100 (Grade D, Sell). DCF value $3.39.
What is the price target of Autolus Therapeutics Ltd (AUTL)?
The analyst target price is $8.81, representing +524.8% upside from the current price of $1.41.
What is the intrinsic value of Autolus Therapeutics Ltd (AUTL)?
Based on our DCF model, intrinsic value is $3.39, a +57.8% margin of safety versus $1.41.
What is Autolus Therapeutics Ltd's revenue?
TTM revenue is $1.08M.

Company info

SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD

Quick metrics

P/S ratio355.35x
ROE-29.60%
Beta2.00
50D MA$1.51
200D MA$1.64
Shares out0.27B
Float0.03B
Short ratio
Avg volume1.7M

Performance

1 week-8.86%
1 month+19.01%
3 months+3.60%
YTD-27.64%
1 year
3 years
5 years